Human prostate cell lines from normal and tumourigenic epithelia differ in the pattern and control of choline lipid headgroups released into the medium on stimulation of protein kinase C

British Journal of Cancer

Volumn 104, Issue 4, 2011, Pages 673-684

  Rumsby, M ^a   Schmitt, J ^a   Sharrard, M ^a   Rodrigues, G ^b   Stower, M ^c   Maitland, N ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b HULL ROYAL INFIRMARY   (United Kingdom)

^c YORK HOSPITAL   (United Kingdom)

Author keywords

choline and phosphocholine release; MARCKS; phospholipase D; prostate epithelial cell lines; protein kinase C

Indexed keywords

CHOLINE; MARCKS PROTEIN; PHORBOL ESTER; PHOSPHOLIPASE D; PHOSPHOLIPID; PHOSPHORYLCHOLINE; PROTEIN KINASE C ALPHA; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C ZETA;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; ION EXCHANGE CHROMATOGRAPHY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CELL LINE, TUMOR; CHOLINE; CULTURE MEDIA; EPITHELIUM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOENZYMES; LIPID METABOLISM; MALE; MEMBRANE PROTEINS; NEOPLASMS, GLANDULAR AND EPITHELIAL; PHOSPHORYLATION; PHOSPHORYLCHOLINE; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN KINASE C-ALPHA; TETRADECANOYLPHORBOL ACETATE;

EID: 79951676802     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6606077     Document Type: Article

References (96)

1. Ackerstaff E, Pflug BR, Nelson JB, Bhujwalla ZM (2001) Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res 61: 3599-3603 (Pubitemid 32694969)
2. Alessi D (1997) The protein kinase C inhibitors Ro318220 and GF 109203X are equally potent inhibitors of MAPKAP kinase-1¡ (Rsk-2) and p70S6 kinase. FEBS Lett 402: 121-123 (Pubitemid 27078242)
3. Ali AS, Ali S, El-Rayes BF, Philip PA, Sarkar FH (2009) Exploitation of protein kinase C: useful target for cancer therapy. Cancer Treat Rev 35: 1-8
4. Baba S, Engles J, Wahl R (2007) Choline uptake and RNA expression profile in cancerous and normal prostate cell lines: No significant role of choline transporter in PET tracer uptake. J Nucl Med 48(Suppl 2): 335P
5. Beloueche-Babari M, Peak JC, Jackson LE, Tiet M-Y, Leach MO, Eccles SA (2009) Changes in choline metabolism as potential biomarkers of phospholipase Cy1 inhibition in human prostate cancer cells. Mol Cancer Ther 8: 1305-1311
6. Berthon P, Cussenot O, Hopwood L, Le Duc A, Maitland NJ (1995) Functional expression of SV40 in normal human prostatic epithelial and fibroblastic cells: differentiation pattern of non-tumorigenic cell lines. Int J Oncol 6: 333-343
7. Cecchetti S, Spadaro F, Lugini L, Podo F, Ramoni C (2007) Functional role of phosphatidylcholine-specific phospholipase C in regulating CD16 membrane expression in natural killer cells. Eur J Immunol 37: 2912-2922 (Pubitemid 47578310)
8. Chen J-S, Exton JH (2004) Regulation of phospholipase D2 activity by protein kinase Ca. J Biol Chem 279: 22076-22083 (Pubitemid 38679399)
9. Choi M-G, Kurnov V, Kersting MC, Sreenivas A, Carman GM (2005) Phosphorylation of the yeast choline kinase by protein kinase C J Biol Chem 280: 26105-26112
10. Chua BT, Gallego-Ortega D, Ramirez de Molina AR, Ullrich A, Lacal JC, Downward J (2009) Regulation of Akt (ser-473) phosphorylation by choline kinase in breast carcinoma cells. Mol Cancer 8: 131
11. Chung T, Crilly KS, Anderson WH, Mukherjee JJ, Kiss Z (1997) ATP-dependent choline phosphate-induced mitogenesis in fibroblasts in-volves activation of pp70 S6 kinase and phosphatidylinositol 3-kinase through an extracellular site. J Biol Chem 272: 3064-3072 (Pubitemid 27053362)
12. Cockcroft S (2001) Signalling roles of mammalian phospholipase D1 and D2. Cell Mol Life Sci 58: 1674-1687 (Pubitemid 32996102)
13. Cook SJ, Wakelam MJO (1989) Analysis of the water-soluble products of phosphatidylcholine breakdown by ion-exchange chromatography. Biochem J 263: 581-587
14. Cornell RB, Northwood IC (2000) Regulation of CTP:phosphocholine cytidylyltransferase by amphitropism and relocalisation. Tr Biochem Sci 25: 441-447 (Pubitemid 30662412)
15. Cornford P, Evans J, Dodson A, Parsons K, Woolfenden A, Neoptolemos J, Foster CS (1999) Protein kinase C isoenzyme patterns characteristically modulated in early prostate cancer. Am J Pathol 154: 137-144 (Pubitemid 29031621)
16. Cuadrado A, Carnero A, Dolfi F, Jimenez B, Lacal JC (1993) Phosphorylcho-line: a novel second messenger essential for mitogenic activity of growth factors. Oncogene 8: 2959-2968 (Pubitemid 23312899)
17. Cussenot O, Berthon P, Faille A, Berger R, Mowszowicz I, Teillac P, LeDuc A, Calvo F (1991) Immortalisation of human adult normal prostate epithelial cells by liposomes containing SV40. J Urol 143: 881-886
18. Dawson J, Hotchin N, Lax S, Rumsby M (2003) Lysophosphatidic acid induces process retraction in CG-4 line oligodendrocytes and oligoden-drocyte precursor cells but not in differentiated oligodendrocytes. J Neurochem 87: 947-957 (Pubitemid 37444570)
19. De Souza PL, Russell PJ, Kearsley J (2009) Role of the Akt pathway in prostate cancer. Curr cancer Drug targets 9: 163-175
20. Eliyahu G, Kreizman T, Degani H (2007) Phosphocholine as a biomarker of breast cancer: molecular and biochemical studies. Int J Cancer 120: 1721-1730 (Pubitemid 46402874)
21. Foster DA (2006) Phospholipase D survival signals as a therapeutic target in cancer. Curr Signal Transduction Ther 1: 295-303
22. Foster DA (2007a) Regulation of mTOR by phosphatidic acid? Cancer Res 67: 1-4 (Pubitemid 46142751)
23. Foster DA (2007b) Phosphatidic acid signalling to mTOR: signals for the survival of cancer cells. Biochim Biophys Acta 1791: 949-955
24. Foster DA (2009) Phosphatidic acid signalling to mTOR: Signals for the survival of human cancer cells. Biochim Biophys Acta 1791: 949-955
25. Foster DA, Xu L (2003) Phospholipase D in cell proliferation and cancer. Mol Cancer Res 1: 789-800 (Pubitemid 37174450)
26. Gallego-Ortega D, Ramirez de Molina AR, Ramos MA, Valdes-Mora F, Barderas MG, Sarmentero-Estrata J, Lacal JC (2009) Differential roles of human choline kinase a and ft enzymes in lipid metabolism: implications in cancer onset and treatment. PLoS ONE 4: e7819
27. Gavrielides MV, Frijhoff AF, Conti CJ, Kazanietz MG (2004) Protein kinase C and prostate carcinogenesis:Targeting the cell cycle and apoptotic mechanisms. Curr Drug Targets 5: 431-443 (Pubitemid 38807817)
28. Gibbs TC, Meier KE (2000) Expression and regulation of phospholipase D isoforms in mammalian cell lines. J Cell Physiol 182: 77-87 (Pubitemid 129710502)
29. Glunde K, Ackerstaff E, Mori N, Jacobs MA, Bhujwalla ZM (2006) Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions. Mol Pharm 3: 496-506 (Pubitemid 44639126)
30. Glunde K, Jie C, Bhujwalla ZM (2004) Molecular causes of the aberrant choline phospholipid metabolism in breast cancer. Cancer Res 64: 4270-4276 (Pubitemid 38802433)
31. Gonzalez-Guerrico AM, Meshki J, Xiao L, Benavides F, Conti CJ, Kazanietz MG (2005) Molecular mechanisms of protein kinase C-induced apoptosis in prostate cancer cells. J Biochem Mol Biol 38: 639-645 (Pubitemid 43240967)
32. Griner EM, Kazanietz MG (2007) Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer7: 281-294 (Pubitemid 46480971)
33. Guertin DA, Sabatini DM (2007) Defining the role of mTOR in cancer. Cancer Cell 12: 9-21
34. Gutcher I, Webb PR, Anderson NG (2003) The isoform-specific regulation of apoptosis by protein kinase C Cell Mol Life Sci 60: 1061-1070 (Pubitemid 36791911)
35. Hara T, Bansal A, DeGrado TR (2006) Choline transporter as novel target for molecular imaging of cancer. Mol Imaging 5: 498-509 (Pubitemid 46142823)
36. Hii CST, Edwards YS, Murray AW (1991) Phorbol ester-stimulated hydrolysis of phosphatidylcholine and phosphatidylethanolamine by phospholipase D in HeLa cells: evidence that the basasl turnover of phosphoglycerides does not involve phospholipase D. J Biol Chem 266: 20238-20243 (Pubitemid 21908451)
37. Hu T, Exton JH (2005) 1-butanol interferes with phospholipase D1 and protein kinase Ca association and inhibits phospholipase D1 basal activity. Biochem Biophys Res Commun 327: 1047-1051 (Pubitemid 40137974)
38. Iorio E, Mezzanzanica D, Alberti P, Spadaro F, Ramoni C, D'Ascenzo S, Millimaggi D, Pavan A, Dolo V, Canevari S, Podo F (2005) Alterations of choline phospholipid metabolism in ovarian tumour progression. Cancer Res 65: 9369-9376 (Pubitemid 41508005)
39. Iorio E, Ricci A, Bagnoli M, Pisanu ME, Castellano G, Vito MD, venturini E, Glunde K, Bhujwalla ZM, Mezzanzanica D, Canevari S, Podo F (2010) Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells. Cancer Res 70: 2126-2135
40. Jimenez B, del Peso L, Montaner S, Esteve P, Lacal JC (1995) Generation of phosphorylcholine as an essential event in the activation of Raf-1 and MAP-kinases in growth factor-induced mitogenic stimulation. J Cell Biochem 57: 141-149
41. Joseph T, Bryant A, Wooden R, Kerkhoff E, Rapp UR, Foster DA (2002) Phospholipase D overcomes cell cycle arrest induced by high intensity Raf signalling. Oncogene 21: 3651-3658 (Pubitemid 34587697)
42. Kang MS, Jung SY, Jung KM, Kim SK, Ahn KH, Kim DK (2008) D609, an inhibitor of phosphatidylcholine-specific phospholipase C, inhibits Group IV cytosolic phospholipase A2. Mol Cells 26: 481-485
43. Katz-Brull R, Seger D, Rivenson-Segal D, Rushkin E, Degani H (2002) Metabolic markers of breast cancer: Enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. Cancer Res 62: 1966-1970 (Pubitemid 34408439)
44. Kim Y, Kim J-E, Lee SD, Lee TG, Kim JH, Park JB, Han JM, jang SK, Suh P-G, Ryu SH (1999) Phospholipase D1 is located and activated by protein kinae C a in the plasma membrane in 3Y1 fibroblast cells. Biochim Biophys Acta 1436: 319-330 (Pubitemid 29242913)
45. Kiss Z (1990) Effects of phorbol ester on phospholipid metabolism. Prog Lipid Res 29: 141-166 (Pubitemid 120036360)
46. Kiss Z, Mukherjee JJ (1997) Phosphocholine and sphingosine-1-phosphate synergistically stimulate DNA synthesis by a MAP kinase-dependent mechanism. FEBS Letts 412: 197-200 (Pubitemid 27310029)
47. Kiss Z, Tomono M, Anderson WB (1994) Phorbol ester selectively stimulates phospholipase D-mediated hydrolysis of phosphatidyletha-nolamine in multidrug resistant MCF-7 human breast carcinoma cells. Biochem J 302: 649-654 (Pubitemid 24289296)
48. Kiss Z, Tomoro M (1995) Compound D609 inhibits phorbol ester-stimulated phospholipase D activity and phospholipase C-mediated phosphatidylethanolamine hydrolysis. Biochim Biophys Acta 1259: 105-108
49. Koivunen J, Aaltonen V, Peltonen J (2006) Protein kinase C (PKC) family in cancer progression. Cancer Letts 235: 1-10
50. Koren R, Ben Meir D, Langzam L, Dekel Y, Konichezky M, Baniel J, Livne PS, Gal R, Sampson SR (2004) Expression of protein kinase C isoenzymes in benign hyperplasia and carcinoma of prostate. Oncol Rep 11: 321-326
51. Krichevsky AM, Gabriely G (2009) miR-21: a small multi-faceted RNA. J Cell Mol Med 13: 39-53
52. Krongrad A, Bai G (1994) c-fos promoter insensitivity to phorbol ester and possible role of protein kinase C in androgen-independent cancer cells. Cancer Res 54: 6073-6077 (Pubitemid 24378632)
53. Lahn M, Sundell K, Gleave M, Ladan F, Su C, Li S, Ma D, Paterson BM, Bumol TF (2004) Protein kinase C-a in prostate cancer. BJU Int 93: 1076-1081 (Pubitemid 38758637)
54. Lamm MGL, Long DD, Goodwin SM, Lee C (1997) Transforming growth factor-/í1 inhibits membrane association of protein kinase C-a in a human prostate cancer cell line, PC3. Endocrinol 138: 4657-4664 (Pubitemid 27460900)
55. Lang SH, Hyde C, Reid IN, Hitchcock IS, Hart CA, Bryden AAG, Villette J-M, Stower MJ, Maitland NJ (2002) Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma. The Prostate 52: 253-263
56. Larsson C (2006) Protein kinase C and the regulation of the actin cytoskeleton. Cell Signal 18: 276-284 (Pubitemid 41661343)
57. Li G, D'Souza-Schorey C, Barbieri MA, Cooper JA, Stahl PD (1997) Uncoupling of membrane ruffling and pinocytosis during Ras signal transduction. J Biol Chem 272: 10337-10340 (Pubitemid 27181029)
58. Li T, Li D, Sha J, Sun P, Huang Y (2009) MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem Biophys Res Commun 383: 280-285
59. Luberto C, Hannun YA (1998) Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. J Biol Chem 273: 14550-14559
60. Macara IG (1989) Elevated phosphocholine concentration in Ras-trans-formed NIH 3T3 cells arises from increased choline kinae activity, not from phosphatidylcholine breakdown. Mol cell Biol 9: 325-328
61. Mackay HJ, Twelves CJ (2007) Targeting the protein kinase C family: are we there yet? Nat Rev Cancer 7: 554-562 (Pubitemid 46985395)
62. Maitland NJ, Macintosh CA, Hall J, Sharrard M, Quinn G, Lang S (2001) In vitro models to study cellular differentiation and function in human prostate cancers. Radiation Res 155: 133-142 (Pubitemid 33723529)
63. Michel V, Yuan Z, Ramsubir S, Bakovic M (2006) Choline transport for phospholipid synthesis. Exp Biol Med 231: 490-504
64. Morreale A, Mallon B, Beale G, Watson J, Rumsby M (1997) Ro31-8220 inhibits protein kinase C to block the phorbol ester-stimulated release of choline and ethanolamine metabolites from C6 glioma cells: p70 S6 kinase and MAPKAP kinase-1/i do not function downstream of PKC in activating PLD. FEBS Lett 417: 38-42 (Pubitemid 27490468)
65. Morris AJ, Frohman MA, Engebrecht J (1997) Measurement of phospho-lipase D activity. Anal Biochem 252: 1-9
66. Mufson RA, Okin E, Weinstein IB (1981) Phorbol esters stimulate the rapid release of choline from prelabelled cells. Carcinogenesis 2: 1095-1102 (Pubitemid 12171117)
67. Muller SA, Holzapfel K, Seidl C, Treiber U, Krause BJ, Senekowitsch-Schmidtke R (2009) Charactyerisation of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatment. Eur J Nucl Med Mol Imaging 36: 1434-1442
68. Muller-Decker K (1989) Interruption of TPA-induced signals by an antiviral and antitumoral xanthate compound: inhibition of a phospho-lipase C-type reaction. Biochem Biophys Res Comm 162: 198-205 (Pubitemid 19185846)
69. Myklebust JH, Smeland EB, Josefsen D, Sioud M (2000) Protein kinase C-a isoform is involved in erythropoietin-induced erythroid differentiation of CD34+ progenitor cells from human bone marrow. Blood 95: 510-518 (Pubitemid 30041663)
70. Nilsson J, Skog J, Nordstrand A, Baranov V, Mincheva-Nilsson L, Breakefield XO, Widmark A (2009) Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Brit J Cancer 100: 1603-1607
71. O'Brian CA (1998) Protein kinase C-a: A novel target for the therapy of androgen-independent prostate cancer? Oncol Rep 5: 305-309
72. Olivier AR, Parker PJ (1992) Identification of multiple PKC isoforms in Swiss 3T3 cells: Differential down-regulation by phorbol ester. J Cell Physiol 152: 240-244
73. Paone A, Starace D, Galli R, Padula F, De Cesaris P, Filippini A, Ziparo E, Riccioli A (2008) Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKCa dependent mechanism. Carcino-genesis 29: 1334-1342
74. Podo F, Ferretti A, Knijn A, Zhang P, Ramoni C, Barletta B, Pini C, Baccarini S, Pulciani S (1996) Detection of phosphatidylcholine-specific phospholipase C in NIH 3T3 fibroblasts and their H-ras transformants: NMR and immunochemical studies. Anticancer Res 16: 1399-1412 (Pubitemid 26257809)
75. Powell CT, Brittis NJ, Stec D, Hug H, Heston WDW, Fair WR (1996) Persistant membrane translocation of protein kinase C a during 12-0-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP numan prostate cancer cells. Cell Growth Differ 7: 419-428 (Pubitemid 26362086)
76. Powell CT, Fair WR, Heston WDW (1994) Differential expression of protein kinase C isozyme messenger RNAs in Dunning R-3327 rat prostatic tumours. Cell Growth Differ 5: 143-149 (Pubitemid 24249666)
77. Ramirez de Molina AR, Gallego-Ortega D, Sarmentero-Estrada J, Lagares D, del Pulgar TG, bandres E, Garcia-Foncillas J, Lacal JC (2008) Choline kinase as a link connecting phospholipid metabolism and cell cycle regulation:implications for cancer therapy. Int J Biochem Cell Biol 40: 1753-1763
78. Ramirez de Molina AR, Rodriguez-Gonzalez A, Gutierrez R, Martinez-Pineiro L, Sanchez JJ, Bonilla F, Rosell R, Lacal JC (2002) Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate and colorectal cancers. Biochem Biophys Res Comm 296: 580-583
79. Ramoni C, Spadaro F, Barletta B, Dupuis ML, Podo F (2004) Phosphati-dylcholine-specific phospholipase C in mitogen-stimulated fibroblasts. Exp Cell Res 299: 370-382
80. Ramoni C, Spadaro F, Menegon M, Podo F (2001) Cellular localisation and functional role of phosphatidylcholine-specific phospholipase C in NK cells. J Immunol 167: 2642-2650 (Pubitemid 32768893)
81. Rombouts K, Lottini B, Caligiuri A, Liotta F, Mello T, Carloni V, Marra F, Pinzani M (2008) MARCKS is a downstream effector in platelet-derived growth factor-induced cell motility in activated human hepatic stellate cells. Exp Cell Res 314: 1444-1454
82. Sharrard RM, Maitland NJ (2007) Regulation of protein kinase B activity by PTEN and SHIP2 in human prostate-derived lines. Cell Signalling 19: 129-138 (Pubitemid 44880249)
83. Spadaro F, Ramoni C, Mezzanzanica D, Miotti S, Alberti P, Cecchetti S, Iorio E, Dolo V, canevari S, Podo F (2008) Phosphatidylcholine-specific phospholipase C activation in epithelial ovarian cancer cells. Cancer Res 68: 6541-6549
84. Stewart JR, O'Brian CA (2005) Protein kinase C-a mediates epidermal growth factor transactivation in human prostate cancer cells. Mol Cancer Ther 4: 726-732 (Pubitemid 40767116)
85. Sundaram M, Cook HW, Byers DM (2004) The MARCKS family of phospholipid binding proteins: regulation of phospholipase D and other cellular components. Biochem Cell Biol 82: 191-200 (Pubitemid 38580883)
86. Tomono M, Crilly KS, Kiss Z (1995) Synergistic potentiating effects of choline phosphate and ethanolamine on insulin-induced DNA synthesis in NIH 3T3 fibroblasts. Biochem Biophys Res Commun 213: 980-985
87. Troyer DA, Gonzalez OF, Padilla RM, Kreisberg JI (1992) Vasopressin and phorbol ester-stimulated phosphatidylcholine metabolism in nesangial cells. Am J Physiol 262: F185-F191
88. Uberall F, Giselbrecht S, Hellbert K, Fresser F, bauer B, Gschwendt M, Grunicke HH, Baier G (1997) Conventional PKCa, novel PKCe and PKCΘ, but not atypical PKC1 are MARCKS kinases in intact NIH 3T3 fibroblasts. J Biol Chem 272: 4072-4078 (Pubitemid 27078470)
89. van Blitterswijk WJ, Hilkmann H, de Widt J, van der Bend RL (1991) Phospholipid metabolism in bradykinin-stimulated fibroblasts. J Biol Chem 266: 10344-10350
90. van Dijk MCM, Muriana FJG, de Widt J, Hilkmann H, van Blitterswijk WJ (1997) Involvement of phosphatidylcholine-specific phospholipase C in platelet-derived growth factor-induced activation of the mitogen-activated protein kinase pathway in Rat-1 fibroblasts. J Biol Chem 272: 11011-11016 (Pubitemid 27184088)
91. Vieira AV, Lamaze C, Schmid SL (1996) Control of EGF receptor signalling by clathrin-mediated endocytosis. Science 274: 2086-2089 (Pubitemid 27020702)
92. Wang T, Li J, Chen F, Zhao Y, He X, Wan D, Gu J (2007) Choline transporters in human lung adenocarcinoma: Expression and functional implications. Acta Biochim Biophys Sinica 39: 668-674 (Pubitemid 47437943)
93. Whiteside TL (2005) Tumour-derived exosomes or microvesicles: another mechanism of tumour escape from the host immune system? Brit J Cancer 92: 209-211 (Pubitemid 40343129)
94. Yalcin A, Clem B, Makoni S, Clem A, Nelson K, Thornburg J, Siow D, Lane AN, Brock SE, Goswami U, Eaton JW, Telang S, Chesney J (2010) Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling. Oncogene 29: 139-149
95. Yoshimoto M, Waki A, Obata A, Furukawa T, Yonekura Y, Fujibayashi Y (2004) Radiolabelled choline as a proliferation marker: comparison with radiolabelled acetate. Nucl Med Biol 31: 859-865 (Pubitemid 39297683)
96. Zhong M, Shen Y, Zheng Y, Joseph T, Jackson D, Beychenok S, Foster DA (2003) Phospholipase D prevents apoptosis in v-Src-transformed rat fibroblasts and MDA-MB-231 breast cancer cells. Biochem Biophys Res Comm 302: 615-619 (Pubitemid 36279575)